Given recent reports showing that Gramd1c is a direct transcriptional target of the bile acid sensing nuclear receptor FXR (Xiao et al., 2023), additional studies are needed to further understand whether Aster-C-driven modulation of bile acid homeostasis may hold therapeutic potential in liver disease (Wang et al., 2020). The gene discussed is GRAMD1C; the disease is liver disorder.